Blanchard Valentin
机构: Department of Medicine, Centre for Heart Lung Innovation, Providence Healthcare Research Institute
每年引用次数
引用次数
引用: 526
H-指数: 14
I10-指数 : 17
出版物: 38
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study
Samy Hadjadj , Pierre-Jean Saulnier , Pierre-Jean Saulnier , Elise Gand
Diabetologia 64 ( 3) 668 -680
1
2021
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function.
Nicolas Diotel , Brice Nativel , Olivier Meilhac , Bertrand Cariou
Atherosclerosis 326 47 -55
11
2021
Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia.
Valentin Blanchard , Mikaël Croyal , Ilya Khantalin , Stéphane Ramin-Mangata
JACC: Basic to Translational Science 4 ( 3) 425 -427
3
2019
Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab
Kévin Chemello , Sandra Beeské , Thi Thu Trang Tran , Valentin Blanchard
JACC: Basic to Translational Science 5 ( 6) 549 -557
3
2020
Key aspects of PCSK9 inhibition beyond LDL lowering
Stéphane Ramin-Mangata , Valentin Blanchard , Gilles Lambert
Current Opinion in Lipidology 29 ( 6) 453 -458
11
2018
VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
Mikaël Croyal , Valentin Blanchard , Khadija Ouguerram , Maud Chétiveaux
Arteriosclerosis, Thrombosis, and Vascular Biology 40 ( 3) 819 -829
5
2020
Stable Isotope Kinetic Study of ApoM (Apolipoprotein M)
Mikaël Croyal , Stéphanie Billon-Crossouard , Sophie Goulitquer , Audrey Aguesse
Arteriosclerosis, Thrombosis, and Vascular Biology 38 ( 1) 255 -261
9
2018
Recurrent coronary syndromes in a patient with isolated very-high lipoprotein (a) and the prothrombin genetic variant rs1799963 (G20210A): a case report.
Ilya Khantalin , Valentin Blanchard , Nicolas Viallet , Gilles Lambert
European Heart Journal - Case Reports 3 ( 1)
2019
PCSK9: from biology to clinical applications
Valentin Blanchard , Ilya Khantalin , Stéphane Ramin-Mangata , Kévin Chémello
Pathology 51 ( 2) 177 -183
24
2019
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.
Stéphane Ramin-Mangata , Matthieu Wargny , Matthieu Pichelin , Cédric Le May
Atherosclerosis 293 49 -56
18
2020
PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate.
Mikaël Croyal , Thi-Thu-Trang Tran , Rose Hélène Blanchard , Jean-Christophe Le Bail
Clinical Science 132 ( 10) 1075 -1083
38
2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study
Valentin Blanchard , Stéphane Ramin-Mangata , Stéphanie Billon-Crossouard , Audrey Aguesse
Journal of Lipid Research 59 ( 5) 892 -900
15
2018
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
Mikaël Croyal , Matthieu Wargny , Kevin Chemello , Chloé Chevalier
Cardiovascular Diabetology 21 ( 1) 1 -11
5
2022
Genome-wide characterization of a highly penetrant form of hyperlipoprotein (a) emia associated with genetically elevated cardiovascular risk
Stefan Coassin , Kevin Chemello , Ilya Khantalin , Lukas Forer
Circulation: Genomic and Precision Medicine 15 ( 2) e003489
4
2022
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors
Valentin Blanchard , Kévin Chemello , Tim Hollstein , Clément Chong Hong-Fong
Cardiovascular Research 118 ( 9) 2103 -2111
26
2022
OPEN ACCESS EDITED BY
Robert Hegele , Daniele Pastori , Hanrui Zhang , Yuan Xinxu
Rare dyslipidemias 113 -113
2023
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor) Implications for the Efficacy of Evolocumab
Aurélie Thedrez , Dirk J Blom , Stéphane Ramin-Mangata , Valentin Blanchard
Arteriosclerosis, thrombosis, and vascular biology 38 ( 3) 592 -598
93
2018
Homozygous FH patients with identical mutations variably express the LDL receptor: implications for the efficacy of evolocumab
Aurélie Thedrez , Dirk J Blom , Stéphane Ramin-Mangata , Valentin Blanchard
Arteriosclerosis, thrombosis, and vascular biology 38 ( 3) 592 -592
5
2018
Genetic and mechanistic insights into the modulation of circulating lipoprotein (a) concentration by apolipoprotein E isoforms
Kévin Chemello , Dirk J Blom , A David Marais , Gilles Lambert
Current Atherosclerosis Reports 24 ( 6) 399 -405
2
2022
Smooth Muscle Cell—Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location
Pinhao Xiang , Valentin Blanchard , Gordon A Francis
Frontiers in Physiology 13 921597 -921597
19
2022